跳至主要内容
临床试验/JPRN-UMIN000010061
JPRN-UMIN000010061已完成未知

Clinical Implications of Triple Combination Therapies(Metformin+Alpha-glucosidase Inhibitor+DPP-4 Inhibitor) in Type 2 Diabetes - Clinical Implications of Triple Combination Therapies(Metformin+Alpha-glucosidase Inhibitor+DPP-4 Inhibitor) in Type 2 Diabetes

SANWA KAGAKU KENKYUSHO CO.,LTD0 个研究点目标入组 45 人开始时间: 2013年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients require insulin or oral antidiabetic drug therapy other than metformin and/or miglitol 2.Female patients who were pregnant,suspected of being pregnant,planning a pregnancy,or lactating 3.Patients with,or a history of,serious renal disease(Serum Creatinine of >=2mg/dL 4.Any patients deemed by the investigator to be ineligible for participation in this study

研究者

发起方
SANWA KAGAKU KENKYUSHO CO.,LTD

相似试验

Clinical Implications of Triple Combination... | 临床试验